Mass Spectrometry

Our team of experts can provide high resolution mass spectrometry as a stand-alone service or as part of API or bioconjugation projects, working closely with clients to meet their technical requirements.

Explore our mass spectrometry focused infographics, one pagers and blogs below to hear from our experts.

All articles

Preview of Sterling high resolution mass spectrometry for impurity profiling whitepaper

Whitepaper1 min read

High resolution mass spectrometry for impurity profiling Read more

One pager2 min read

Disulfide bond mapping of a monoclonal therapeutic antibody Read more

Picture of Chris Nortcliffe, Mass Spectrometry Manager at Sterling's Deeside, Wales facility

Spotlight6 min read

Scientist Snapshot | Chris Nortcliffe, Mass Spectrometry Manager Read more

One pager2 min read

Total antibody quantification of an ADC after plasma incubation

A key feature of monoclonal antibody (mAb) proteins is their stability in plasma due to their resistance to proteases.

One pager2 min read

Reduced subunit analysis of a PDB based antibody drug conjugate

Subunit analysis of Zynlonta using a SCIEX X500B Mass Spectrometer

Picture of Chris Nortcliffe, Mass Spectrometry Manager at Sterling, presenter of "The use of mass spectrometry to aid ADC development" webinar

Webinar13 min read

The use of mass spectrometry to aid ADC development Read more

One pager3 min read

Measurement of ADC free drug after plasma incubation

Antibody drug conjugates (ADCs) combine a monoclonal antibody (mAb) scaffold with a number of cytotoxic drugs.

News2 min read

Sterling expands ADC capabilities and laboratory capacity at Deeside

Sterling Pharma Solutions today announced a £1 million expansion project at its Deeside, UK site, which is the company’s dedicated bioconjugation and antibody-drug conjugates (ADCs) facility. The project will increase the current laboratory space from 275 to 419 square meters and establish cGMP bioconjugation/ADC manufacturing capabilities.

One pager2 min read

Native intact analysis of a cysteine linked antibody drug conjugate

Native intact analysis of Brentuximab Vedotin using a SCIEX X500B Mass Spectrometer

Explore more

All ADCs API Development API Manufacturing Analytical Services Drug Discovery Facilities News PDMO People Peptides Sustainability Technologies

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

Company

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy